Amylx Pharmaceuticals Inc vs OneSpan Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 4.4× OneSpan Inc's market cap, and OneSpan Inc pays a 3.19% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | OSPN | |
|---|---|---|
Market Cap | $2.64B | $600.69M |
Sector | Health | Technology |
52-Week High | $24.19 | $16.78 |
52-Week Low | $7.82 | $10.15 |
Enterprise Value | $2.39B | $569.77M |
Dividend Yield | — | 3.19% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →